Table 1 Differences in characteristics between fibrocavitary and nodular bronchiectatic types (N = 27)

Number (%)

6 (22)

21 (78)

Age (y)

75 (61–78)

71 (64–78)

NS

Men (%)

2 (33)

3 (14)

NS

BMI (kg/m²)

16.5 ± 2.7

19.5 ± 2.5

< 0.05

Anemia (%)

3 (50)

7 (33)

NS

Iron deficiency (%)

2 (33)

3 (14)

NS

Undernutrition (%)

5 (83)

8 (38)

NS

With immunosuppressive drug (%)

0 (0)

7 (29)

NS

Untreated at baseline (%)

1 (17)

14 (67)

NS

 Mycobacterium. avium

5 (83)

16 (76)

 Mycobacterium. intracellulare

1 (17)

3 (14)

 M. avium and M. intracellulare

0 (0)

2 (10)

Lymphocytes (/μL)

1095 ± 307

1329 ± 417

NS

Red blood cells (× 10⁴/μL)

422 ± 39

418 ± 52

NS

Hb (g/dL)

12.5 ± 1.2

12.7 ± 1.5

NS

Albumin (g/dL)

3.1 (3.0–3.9)

4.0 (3.7–4.1)

< 0.01

Pre-albumin (mg/dL)

14.7 ± 10.0

21.9 ± 3.9

NS

Fe (μg/dL)

49 (19–105)

84 (49–109)

NS

UIBC (μg/dL)

192 ± 34

184 ± 70

NS

TIBC (μg/dL)

251 ± 37

265 ± 64

NS

TSAT (%)

22.6 ± 14.8

32.3 ± 17.2

NS

Ferritin (ng/mL)

74 (23–159)

48 (19–107)

NS

CRP (mg/dL)

4.6 (0.2–6.9)

0.1 (0.1–1.2)

< 0.05

SAA (mg/dL)

241.5 (6.3–726.2)

3.7 (2.4–28.7)

NS

ESR (mm/hr)

70 (31–96)

19 (750)

< 0.05

Anti-GPL core antibody positive (%)

5 (83)

11 (52)

NS

HRCT scores

25 (12–31)

9 (6–15)

< 0.05